Alpha Cognition (ACOG) Liabilities and Shareholders Equity (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Liabilities and Shareholders Equity came in at $79.7 million in Q4 2025, up 57.14% year-on-year from $50.7 million in Q4 2024, and up 72.2% quarter-over-quarter from $46.3 million in Q3 2025.
Alpha Cognition (ACOG) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Alpha Cognition's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $79.7 million for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 57.14% year-over-year to $79.7 million in Q4 2025; TTM through Dec 2025 was $219.8 million, a 279.9% increase from a year earlier, with the FY2025 full-year figure at $79.7 million, up 57.14% from the prior year.
- Liabilities and Shareholders Equity climbed to $79.7 million in Q4 2025 per ACOG's latest filing, from $46.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $79.7 million in Q4 2025 and bottomed at $2.1 million in Q2 2024.
- The 3-year median for Liabilities and Shareholders Equity is $45.7 million (2025), against an average of $35.0 million.
- Biggest YoY gain for Liabilities and Shareholders Equity was 2067.29% in 2025; the steepest drop was 57.14% in 2025.
- Year by year, Liabilities and Shareholders Equity stood at $2.5 million in 2023, then jumped by 1969.06% to $50.7 million in 2024, then jumped by 57.14% to $79.7 million in 2025.
- Per Business Quant, the three latest ACOG Liabilities and Shareholders Equity figures stand at $79.7 million (Q4 2025), $46.3 million (Q3 2025), and $45.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 79.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.73 Mn |
| Sep 30, 2025 | 46.30 Mn |
| Jun 30, 2025 | 45.12 Mn |
| Mar 31, 2025 | 48.61 Mn |
| Dec 31, 2024 | 50.74 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.45 Mn |